Amryt Pharma plc (LON:AMYT – Get Free Report) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 143 ($1.78) and traded as low as GBX 143 ($1.78). Amryt Pharma shares last traded at GBX 143 ($1.78), with a volume of 90,727 shares trading hands.
Amryt Pharma Price Performance
The stock has a market cap of £457.11 million and a PE ratio of -4.33. The company has a debt-to-equity ratio of 66.05, a current ratio of 1.80 and a quick ratio of 1.14. The business has a fifty day moving average of GBX 143 and a 200 day moving average of GBX 143.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
See Also
- Five stocks we like better than Amryt Pharma
- Energy and Oil Stocks Explained
- Silicon Motion Proves That AI in Motion Stays in Motion
- How to Calculate Options Profits
- Undervalued UnitedHealth Group Won’t Be For Long
- What is a SEC Filing?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
